Adding to the difficulty, several of the vaccines now in late-stage trials require two doses per person — doubling the manufacturing need.
Adding to the difficulty, several of the vaccines now in late-stage trials require two doses per person — doubling the manufacturing need.
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться